Samsung Medison, a medical system unit of Samsung Electronics that makes a speciality of growing diagnostic imaging units, mentioned on Wednesday it plans to amass Sonio, a Paris-based startup that makes AI-powered software program for ultrasound workflows, for about $92.7 million (KRW 126 billion).
The French startup’s AI assistant is geared toward serving to obstetricians and gynecologists with the analysis and documentation of ultrasound exams, and it has additionally acquired regulatory clearance in the US (FDA 510(okay)) for Sonio Detect, a product that makes use of deep studying algorithms to enhance the picture high quality of ultrasound scans in actual time.
Samsung Medison mentioned Sonio’s software program would assist it deliver higher AI-driven imaging workflows to the market. Samsung Electronics, which owns a 68.45% stake within the medical system unit, acquired Medison for $22 million in 2011.
Samsung mentioned in an announcement that following the acquisition, Sonio will stay an unbiased firm and proceed to develop commercially and supply services and products in France.
Co-founded by Cecile Brosset (CEO) and Remi Besson (CSO) in 2020, Sonio most lately secured $14 million in a Collection A led by Cross Border Affect Ventures in August 2023. The corporate has raised a complete of $27.2 million, in accordance with Tracxn, and its traders embrace Elaia, Bpifrance French Tech Seed, OneRagtime, and some angel traders.
“Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” mentioned Yong Kwan Kim, CEO of Samsung Medison. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”
“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” mentioned Brosset, CEO of Sonio. “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.”